Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-05-31
2011-05-31
Myers, Carla (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200, C536S023500, C536S024310
Reexamination Certificate
active
07951538
ABSTRACT:
A new method is found to determine an increased risk for side effects of an SSRI treatment in a person by genotyping the person for the presence of the 102 C/C DNA sequence in the 5-HT2Areceptor gene. This provides for a method to improve the treatment of an SSRI responsive disorder and in particular depression.
REFERENCES:
patent: 7083921 (2006-08-01), Murphy et al.
patent: 2006/0228750 (2006-10-01), Murphy et al.
patent: WO 96/17801 (1996-06-01), None
Kato et al. Psychiatry Research. 2009. 167: 97-105.
Lucentini et al. The Scientist, Dec. 2004, p. 20.
Oswald et al. “Lack of association between the 5HT2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European study.” European Neuropsychopharmacology (2003) 13(5):365-368.
Fehr et al. “Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy.” Progress in Neuro-Psychopharmacology and Biological Psychiatry (2001) 25(5):965-982.
Du et al. “Association of Polymorphism of Serotonin 2A Receptor Gene with Suicidal Ideation in Major Depressive Disorder,” American Journal of Medical Genetics (Neuropsychiatric Genetics) (2000) 96:56-60.
Chen et al. “Lack of Allelic Association Between 102T/C Polymorphism of Serotonin Receptor Type 2A Gene and Schizophrenia in Chinese,” Psychiatric Genetics (1997) 7:35-38.
Murphy et al. “Pharmacogenetics of Antidepressant Medication Intolerance,” Am. J. Psychiatry (2003) 160 (10):1830-1835.
Kato et al. “Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients.” Neuropsychobiology, 2006, 53: 186-195.
Murphy Greer M.
Schatzberg Alan F.
Borden Paula A.
Bozicevic Field and Francis LLP
Myers Carla
The Board of Trustees of the Leland Stanford Junior Univeristy
LandOfFree
Method to determine the risk for side effects of an SSRI... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to determine the risk for side effects of an SSRI..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to determine the risk for side effects of an SSRI... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2623571